作者：
Diana Vladimirovna,Yuzhakova [1]
;
Lilia N,Volchkova [1]
;
Mikhail Valerievich,Pogorelyy [2]
;
Ekaterina O,Serebrovskaya [3]
;
Irina A,Shagina [2]
;
Ekaterina A,Bryushkova [3]
;
Tatiana O,Nakonechnaya [2]
;
Anna V,Izosimova [3]
;
Daria S,Zavyalova [3]
;
Maria M,Karabut [4]
;
Mark,Izraelson [1]
;
Igor V,Samoylenko [2]
;
Vladimir E,Zagainov [3]
;
Dmitriy M,Chudakov [1]
;
Elena V,Zagaynova [1]
;
George Vladimirovich,Sharonov [1]
作者单位：
Laboratory of Genomics of Antitumor Adaptive Immunity, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
[1]
Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
[2]
Department of Molecular Technologies, Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.
[3]
Department of Molecular Biology, Moscow State University, Moscow, Russia.
[4]
Oncodermatology Department, N. N. Blokhin Russian Cancer Research Center, Moscow, Russia.
[5]
Volga District Medical Centre Under Federal Medical and Biological Agency, Nizhny Novgorod, Russia.
[6]
Adaptive Immunity Group, Central European Institute of Technology, Masaryk University, Brno, Czechia.
[7]
MiLaboratory LLC, Skolkovo Innovation Centre, Moscow, Russia.
[8]
DOI
10.3389/fonc.2020.00512
PMID
32457825
发布时间
2020-09-28
换一批
换一批
